TGF-β1 Inhibits the Release of Histamine and Tumor Necrosis Factor-α from Mast Cells Through an Autocrine Pathway

American Journal of Respiratory Cell and Molecular Biology

Volumn 16, Issue 3, 1997, Pages 275-282

  Bissonnette, Elyse Y ^a   Enciso, J Antonio ^b   Refus, A Dean ^b  

^a UNIVERSITY OF ALBERTA   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

HISTAMINE; MESSENGER RNA; NITRIC OXIDE; PARASITE ANTIGEN; RECOMBINANT GAMMA INTERFERON; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL; ARTICLE; BIOSYNTHESIS; CELL CULTURE; CYTOLOGY; GENE EXPRESSION; GENETICS; HISTAMINE RELEASE; IMMUNOLOGY; MALE; MAST CELL; METABOLISM; NIPPOSTRONGYLUS; PERITONEAL CAVITY; PHYSIOLOGY; RAT; SECRETION; SPRAGUE DAWLEY RAT;

ANIMALS; ANTIGENS, HELMINTH; CELLS, CULTURED; GENE EXPRESSION; HISTAMINE; HISTAMINE RELEASE; INTERFERON-GAMMA, RECOMBINANT; MALE; MAST CELLS; NIPPOSTRONGYLUS; NITRIC OXIDE; PERITONEAL CAVITY; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0031093963     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/ajrcmb.16.3.9070612     Document Type: Article

References (56)

1. Fausto, N. 1991. Multifunctional roles for transforming growth factor-β1. Lab. Invest. 65:497-499.
2. Attisano, L., J. L. Wrana, F. López-Casillas, and J. Massagué. 1994. TGF-β receptors and actions. Biochim. Biophys. Acta 1222:71-80.
3. Border, W. A., and E. Ruoslahti. 1992. Transforming growth factor-β in disease: the dark side of tissue repair. J. Clin. Invest. 90:1-7.
4. Roberts, A. B., M. B. Sporn, R. K. Assoian, J. M. Smith, N. S. Roche, L. M. Wakefield, U. I. Heine, L. A. Liotta, V. Falanga, J. H. Kehrl, and A. S. Fauci. 1986. Transforming growth factor-β: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc. Natl. Acad. Sci. USA 83:4167-4171.
5. 2 production. J. Biol. Chem. 264:11554-11557.
6. Raghu, G., S. Masta, D. Meyers, and A. S. Narayanan. 1989. Collagen synthesis by normal and fibrotic human lung fibroblasts and the effect of transforming growth factor-β. Am. Rev. Respir. Dis. 140:95-100.
7. Linnala, A., V. Kinnula, L. A. Laitinen, V.-P. Lehto, and I. Virtanen. 1995. Transforming growth factor-β regulates the expression of fibronectin and tenascin in BEAS 2B human bronchial epithelial cells. Am. J. Respir. Cell Mol. Biol. 13:578-585.
8. Bienlowsli, R., and M. G. Gotkin. 1995 Control of collagen deposition in mammalian lung. Proc. Soc. Exp. Biol. Med. 209:118-140.
9. Ruscetti, F., L. Varesio, A. Ochoda, and J. Ortaldo. 1993. Pleiotropic effects of transforming growth factor-β on cells of the immune system. Ann. N.Y. Acad. Sci. 685:488-500.
10. Shull, M. M., I. Ormsby, A. B. Kier, S. Pawlowski, R. J. Diebold, M. Yin, R. Allen, C. Sidman, G. Proetzel, D. Calvin, N. Annunziata, and T. Doetschman. 1992. Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease. Nature 359:693-699.
11. Kulkarni, A. B., C. G. Huh, D. Becker, A. Geiser, M. Lyght, K. C. Flanders, A. B. Roberts, M. B. Sporn, J. M. Ward, and S. Karlsson. 1993. Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death. Proc. Natl. Acad. Sci. USA 90:770-774.
12. Wahl, S. M., D. A. Hunt, L. M. Wakefield, N. McCartney-Francis, L. M. Wahl, A. B. Roberts, and M. B. Sporn. 1987. Transforming growth factor type β induces monocyte chemotaxis and growth factor production. Proc. Natl. Acad. Sci. USA 84:5788-5792.
13. Chantry, D., M. Turner, E. Abney, and M. Feldmann. 1989. Modulation of cytokine production by transforming growth factor-β. J. Immunol. 142:4295-4300.
14. Tsunawaki, S., M. Sporn, A. Ding, and C. Nathan. 1991. Deactivation of macrophages by transforming growth factor-β. Nature 334:260-262.
15. Ding, A., C. F. Nathan, J. Graycar, R. Derynck, D. J. Stuehr, and S. Srimal. 1990. Macrophage deactivating factor and transforming growth factors-β1, -β2, and -β3 inhibit induction of macrophage nitrogen oxide synthesis by IFN-γ. J. Immunol. 145:940-944.
16. Förstermann, U., H. H. H. W. Schmidt, K. L. Kohlhaas, and F. Murad. 1992. Induced RAW 246.7 macrophages express soluble and particulate nitric oxide synthase: inhibition by transforming growth factor-β. Eur. J. Pharmacol. 225:161-165.
17. Kehrl, J. H., A. Taylor, S.-J. Kim, and A. S. Fauci. 1991. Transforming growth factor-β is a potent negative regulator of human lymphocytes. Ann. N.Y. Acad. Sci. 628:345-353.
18. Befus, A. D. 1994. Inflammation: mast cells. Cells, regulation and specificity in the mucosal immune system: effector sites. In Mucosal Immunology. P. L. Ogra, J. Mestecky, M. Lamm, W. Strober, J. McGhee, and J. Bienenstock, editors. Academic Press Inc., Orlando Press, San Diego, CA. 307-314.
19. 1. J. Clin. Invest. 90:35-41.
20. εRI. Role for mast cell-derived transforming growth factor β and tumor necrosis factor α. J. Exp. Med. 180:2127-2137.
21. Hu, Z.-Q., T. Yamazaki, Z. Cai, T. Yoshida, and T. Shimamura. 1994. Mast cells display natural suppressor activity partially by releasing transforming growth factor-β. Immunology 82:482-486.
22. Gordon, J. R., P. R. Burd, and S. J. Galli. 1990. Mast cells as a source of multifunctional cytokines. Immunol. Today 11:458-464.
23. Moller, A., U. Lippert, D. Lessmann, G. Kolde, K. Hamann, P. Welker, D. Schadendorf, T. Rosenbach, T. Luger, and B. M. Czarnetzki. 1993. Human mast cells produce IL-8. J. Immunol. 151:3261-3266.
24. Moore, K. W., P. Vieira, D. F. Fiorentino, M. L. Trounstine, T. A. Khan, and T. R. Mosmann. 1990. Homology of cytokine synthesis inhibitory factor (IL-10) to the Epstein-barr virus gene BCRFI. Science 248:1230-1234.
25. Chanez, P., J.-Y. Lacoste, B. Guillot, J. Giron, G. Barnéon, I. Enander, P. Codard, F.-B. Michel, and J. Bousquet. 1993. Mast cells' contribution to the fibrosing alveolitis of the scleroderma lung. Am. Rev. Respir. Dis. 147:1497-1502.
26. Khalil, N., R. N. O'Connor, H. W. Unruh, P. W. Warren, K. C. Flanders, A. Kemp, O. H. Bereznay, and A. H. Greenberg. 1991. Increased production and immunohistochemical localization of transforming growth factor-β in idiopathic pulmonary fibrosis. Am. J. Respir. Cell Mol. Biol. 5:155-162.
27. Meade, R., P. W. Askenase, G. P. Geba, K. Neddermann, R. O. Jacoby, and R. D. Pasternak 1992. Transforming growth factor-β inhibits murine immediate and delayed type hypersensitivity. J. Immunol. 149:521-528.
28. Bissonnette, E. Y., and A. D. Befus. 1990. Inhibition of mast cell-mediated cytotoxicity by IFN-α/β and -γ. J Immunol. 145:3385-3390.
29. Lee, T. D. G., F. Shanahan, H. R. P. Miller, J. Bienenstock, and A. D. Befus. 1985. Intestinal mucosal mast cells: isolation from rat lamina propria and purification using unit gravity velocity sedimentation. Immunology 55:721-728.
30. White, J. R., and F. L. Pearce. 1982. Characteristics of histamine secretion from rat peritoneal mast cells sensitized to the nematode Nippostrongylus brasiliensis. Immunology 46:353-359.
31. Shore, P. A., A. Burkhalter, and V. H. Cohn, Jr. 1959. A method for the fluorometric assay of histamine in tissues. J. Pharmacol. Exp. Ther. 127: 182-186.
32. Pross, H. F., M. G. Baines, P. Rubin, P. Shragge, and M. S. Patterson. 1981. Spontaneous human lymphocyte-mediated cytotoxicity against tumor target cells. IX. The quantification of natural killer activity. J. Clin. Immunol. 1:51-63.
33. Bissonnette, E. Y., C. M. Hogaboam, J. L. Wallace, and A. D. Befus. 1991. Potentiation of TNFα-mediated cytotoxicity of mast cells by their production of nitric oxide. J. Immunol. 147:3060-3065.
34. Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156-159.
35. Sambrook, J. E., F. Fritsch, and T. Maniatis. 1989. Molecular Cloning: A Laboratory Manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
36. Pennica, D., J. S. Hayflick, T. S. Bringman, M. A. Palladino, and D. V. Goeddel. 1985. Cloning and expression in Escherichia coli of the cDNA for murine tumour necrosis factor. Proc. Natl. Acad. Sci. USA 82:6060-6064.
37. Sillaber, C., D. Bevec, J. H. Butterfield, C. Heppner, R. Valenta, O. Scheiner, D. Kraft, K. Lechner, P. Bettelheim, and P. Valent. 1993. Tumor necrosis factor α and interleukin-1 mRNA expression in HMC-1 cells: differential regulation of gene product expression by recombinant interleukin-4. Exp. Hematol. 21:1271-1275.
38. Enciso, J. A., E. Y. Bissonnette, and A. D. Befus. 1996. Regulation of mRNA of TNFα and the alpha chain of the high affinity receptor for IgE in mast cells by interferons γ and α/β. Int. Arch. Allergy Immunol. 110:114-123.
39. 1 selectively inhibits IL-3-dependent mast cell proliferation without affecting mast cell function or differentiation. J. Immunol. 143:1591-1597.
40. Theoharides, T. C., S. K. Kops, P. K. Bondy, and P. W. Askenase. 1985. Differential release of serotonin without comparable histamine under diverse conditions in the rat mast cell. Biochem. Pharmacol. 34:1389-1398.
41. Swieter, M., W. A. Ghali, C. Rimmer, and D. Befus. 1989. Interferon-α/β inhibits IgE-dependent histamine release from rat mast cells. Immunology 66:606-610.
42. Bissonnette, E. Y., B. Chin, and A D. Befus. 1995. Interferons differentially regulate histamine and TNF-alpha in rat intestinal mucosal mast cells. Immunology 86:12-17.
43. Twardzik, D. R., J. A. Mikovits, J. E. Ranchalis, A. F. Purchio, L. Ellingsworth, and F. W. Ruscetti. 1990. γ-Interferon-induced activation of latent transforming growth factor-β by human monocytes. Ann. N.Y. Acad. Sci. 593:276-284
44. Burd, P. R., H. W. Rogers, J. R. Gordon, C. A. Martin, S. Jayaraman, S. D. Wilson, A. M. Dvorak, S. J. Galli, and M. E. Dorf. 1989. Interleukin 3-dependent and -independent mast cells stimulated with IgE and antigen express multiple cytokines. J. Exp. Med. 170:245-257.
45. εRI or to calcium ionophores. Nature 339:64-67.
46. Williams, C. M. M., and J. W. Coleman. 1995. Induced expression of mRNA for IL-5, IL-6, TNF-α, MIP-2 and IFN-γ in immunologically activated rat peritoneal mast cells: inhibition by dexamethasone and cyclosporin A. Immunology 86:244-249.
47. Masini, E., F. Gambassi, M. G. Di Bello, L. Mugnai, S. Raspanti, and P. F. Mannaioni. 1994. Nitric oxide modulates cardiac and mast cell anaphylaxis. Agents Actions 41:C89-C90.
48. Bissonnette, E. Y. 1995. Histamine inhibits tumor necrosis factor α release by alveolar macrophages and mast cells. Am. J. Respir. Crit. Care Med. 151:A136.
49. Befus, A. D., N. Johnston, and J. Bienenstock. 1979. Nippostrongylus brasiliensis: mast cells and histamine levels in tissues of infected and normal rats. Exp. Parasitol. 48:1-8.
50. Gordon, J. R., and S. J. Galli. 1990. Mast cells as a source of both preformed and immunologically inducible TNF-α/cachectin. Nature 346:274-276.
51. Marshall, J. S., I. Leal-Berumen, L. Nielsen, M. Glibetic, and M. Jordana. 1996. Interleukin (IL)-10 inhibits long-term IL-6 production but not preformed mediator release from rat peritoneal mast cells. J. Clin. Invest. 97:1122-1128.
52. Bissonnette, E. Y., J. A. Enciso, and A. D. Befus. 1996. Inhibitory effects of sulfasalazine and its metabolites on histamine release and TNF-α production by mast cells. J. Immunol 156:218-223.
53. Benyon, R. C., M. A. Lowman, P. H. Rees, S. T. Holgate, and M. K. Church. 1989. Mast cell heterogeneity. In Asthma Reviews, Vol. 2. J. Morley, editor. Academic Press, London. 151-189.
54. Phan, S. H., and S. L. Kunkel. 1992. Lung cytokine production in bleomycin-induced pulmonary fibrosis. Exp. Lung. Res. 18:29-43.
55. Gordon, J., A. Katira, A. J. Strain, and S. Gillis. 1991. Inhibition of interleukin 4-promoted CD23 production in human B lymphocytes by transforming growth factor-beta, interferons or anti-CD19 antibody is overridden on engaging CD40. Eur. J. Immunol. 21:1917-1922.
56. Sad, S., and T. R. Mosmann. 1994. Single IL-2-secreting precursor CD4 T cell can develop into either Th1 or Th2 cytokine secretion phenotype. J. Immunol. 153:3514-3522.